Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Vaccines
•
Allergy & Immunology
Why are influenza and COVID vaccines still recommended for patients on immunoglobulin replacement therapy?
Related Questions
Do mRNA vaccines lead to increased rates of acute/chronic urticaria?
Do you consider immunoglobulin replacement in a patient who has rapidly waning vaccine titers but does appropriately respond to revaccination?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
How long do you counsel patients to wait after rituximab therapy before getting live vaccines?
Do patients with a PEG allergy have a contraindication to receiving mRNA vaccines?
Does splitting the dose of a vaccine during an observed administration affect the efficacy of the vaccine response?
What treatments do you consider for cholinergic urticaria refractory to high dose H1 blockers and omalizumab?
Is immunoglobulin replacement an option for CRS in a patient with normal immune function?
How do you manage recurrent epistaxis from nasal steroids?
Do you find that hydroxyzine worsens cognitive symptoms in patients who are already susceptible to cognitive impairment (i.e., schizophrenia, ADHD, dementia)?
